期刊文献+

HPLC法测定不同厂家阿托伐他汀钙片剂的溶出度 被引量:3

Determination of the dissolution of atorvastatin calcium tablets by HPLC
下载PDF
导出
摘要 目的 建立高效液相色谱法测定阿托伐他汀钙片的溶出度.方法 采用DiamonsilC18(250mmx4.6mm,5μm)色谱柱;以醋酸铵缓冲液(pH=4.0)-乙腈-甲醇-四氢呋喃(45:35:13:7)为流动相;检测波长:244nm;流速:1.0mL·min-1;柱温:30℃.测定阿托伐他汀钙片的溶出度.结果 阿托伐他汀钙在128.2~278.5μg·mL-1范围内线性关系良好.回归方程为:y=23637x-3542,r=0.9997.辉瑞制药的立普妥和国产的阿托伐他汀钙片的溶出度均高于国家规定标准.在30min前国产阿托伐他汀钙片与辉瑞制药的立普妥的溶出度存在着不同程度的差异,立普妥溶出速度较快.结论 所建立的高效液相适用于测定阿托伐他汀钙片的溶出度. OBJECTIVE To establish a HPLC method for the determination of dissolution of atorvastatin calci- um tablets. METHODS The chromatographic seperation was performed on Diamonsil ClS (250mmx4.6mm,5μm) column, using ammonium acetate buffer solution ( pH = 4.0) -acetonitrile-mcthanol-tetrahydrofuran (45 : 35:13 : 7 ) as mobile phase,detected at 244 ran. The flow rate was 1.0mL· min-1 ,the column temperature was 30℃. RESULTS The linear range was 128.2 - 278.5μL· min-1. The regression euation was y = 23637x - 3542, r = 0. 9997. It is found that the dissolution rates of Lipitor and that of atorvastatin calcium tablets were both higher than the National Standards. The results showed that there was some differences between the dissolution behavior of imported atorvasta- tin calcium tablets and that of domestic atorvastatin calcium tablets. In the early 30 mins, the dissolution rates of imported atorvastatin calcium tabletswas faster than that of domestic atorvastatin calcium tablets. CONCLUSION HPLC method is suitable for the determination of dissolution of atorvastatin calcium tablets.
出处 《海峡药学》 2013年第10期57-59,共3页 Strait Pharmaceutical Journal
关键词 阿托伐他汀钙片 高效液相色谱法 溶出度 Atorvastatin calcium tablets HPLC Dissolution
  • 相关文献

参考文献2

二级参考文献7

  • 1Kadav AA,Vora DN. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets[ J ]. J Pharm Biomed Anal ,2008,48 (1):120- 6.
  • 2Mohammadi A, Rezanour N, Ansari Dogaheh M, et al. A stability - indicating high performance liquid chromatographic ( HPLC ) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets[ J]. J Chromatogr B Analyt Technol Biomed Life Sci. 2007,846( 1 -2) :215 -21.
  • 3Joseph L, George M, Rao B VR. Simultaneous estimation of atorvastatin and ramipril byRP-HPLC and spectroscopy [ J ]. Pak J Pharm Sci,2008,21 (3) :282 -4.
  • 4Chaudhari BG, Patel NM, Shah PB. Stability indicating RP-HPLC method for simuhaneousdetermination of atorvastatin and amlodipine from their combination durg products [ J ]. ChemPharm Bull ( Tokyo) ,2007,55(2) :241 -6.
  • 5Stanisz B, Kania L. Validation of HPLC method for determination of atorvastatin in tablets andfor monitoring stability in solid phase[ J]. Acta Pol Pharm,2006,63(6) :471 -6.
  • 6邓大同.糖尿病与脂代谢异常[J].安徽医药,2008,12(3):195-198. 被引量:15
  • 7封宇飞,刘志鹤,吴学军,姜文清,邹定.毛细管区带电泳法测定阿托伐他汀钙片的含量及降解产物[J].中国药学杂志,2003,38(6):456-458. 被引量:17

共引文献12

同被引文献22

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部